New product strategy
Focusing on the four key areas, combined with the Group's existing product lines and production lines, we will screen varieties with high clinical value and good market prospects, and reserve varieties to enhance Jingfeng's future market competitiveness.
| ○ Speed | ○ Business | ○ Service |
Platform construction
Build two national new product research and development and process innovation platforms for diabetes and external drugs
R&D model
Chemical medicine is the mainstay, supplemented by traditional Chinese medicine; Imitation and generic drugs are the mainstay, and the generic drugs is supplemented
Choose the opportunity to enter innovative drugs
Breed selection
Priority is given to raw material matching, channel support, and centralized procurement varieties
Research and development process
New drug project
Feasibility analysis report Project decision-making Project approval | 
Technical study
Prescription process optimization Prescription amplification study Process research report PROC | 
Quality research
Method development and establishment Methodological validation Method validation report quality standard | 
Process validation
Validation scheme Validation report batch manufacturing records | 
Registration declaration
Declaration of information on-site verification | 
Declaration approved
Supplementary information Production approval certificate |
Service platform
Research and development + production
One-system efficient
Production and commercialization go hand in hand
Customized service
API &FDF are kept in parallel
Complete production line
扫描二维码分享到微信